GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q1 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $27,737,000 | +26.1% | 753,728 | +29.0% | 0.01% | 0.0% |
| Q3 2020 | $21,999,000 | -39.9% | 584,455 | -34.9% | 0.01% | -45.5% |
| Q2 2020 | $36,603,000 | +7.7% | 897,360 | 0.0% | 0.01% | -8.3% |
| Q1 2020 | $34,001,000 | +7.8% | 897,360 | +33.7% | 0.01% | +33.3% |
| Q4 2019 | $31,531,000 | +27.2% | 671,006 | +15.6% | 0.01% | +12.5% |
| Q3 2019 | $24,782,000 | -1.5% | 580,648 | -7.6% | 0.01% | 0.0% |
| Q2 2019 | $25,160,000 | +33.2% | 628,690 | +39.1% | 0.01% | +33.3% |
| Q1 2019 | $18,893,000 | +9.4% | 452,096 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $17,275,000 | -4.9% | 452,096 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $18,161,000 | +26.9% | 452,096 | +27.3% | 0.01% | +20.0% |
| Q2 2018 | $14,314,000 | +3.2% | 355,103 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $13,874,000 | +10.1% | 355,103 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $12,596,000 | -37.8% | 355,103 | -28.8% | 0.01% | -37.5% |
| Q3 2017 | $20,249,000 | -5.8% | 498,739 | 0.0% | 0.01% | -11.1% |
| Q2 2017 | $21,506,000 | +2.3% | 498,739 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $21,027,000 | +9.5% | 498,739 | 0.0% | 0.01% | +12.5% |
| Q4 2016 | $19,206,000 | -6.5% | 498,739 | 0.0% | 0.01% | -20.0% |
| Q3 2016 | $20,545,000 | -5.0% | 498,739 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $21,615,000 | +6.9% | 498,739 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $20,224,000 | +0.5% | 498,739 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $20,124,000 | +4.9% | 498,739 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $19,177,000 | -52.6% | 498,739 | -48.6% | 0.01% | -50.0% |
| Q2 2015 | $40,440,000 | -9.8% | 970,940 | 0.0% | 0.02% | -9.1% |
| Q1 2015 | $44,809,000 | +8.0% | 970,940 | 0.0% | 0.02% | +4.8% |
| Q4 2014 | $41,498,000 | -7.0% | 970,940 | 0.0% | 0.02% | -12.5% |
| Q3 2014 | $44,634,000 | -57.0% | 970,940 | -50.0% | 0.02% | -14.3% |
| Q2 2014 | $103,852,000 | +100.2% | 1,941,880 | +100.0% | 0.03% | -3.4% |
| Q1 2014 | $51,877,000 | +0.1% | 970,940 | 0.0% | 0.03% | -3.3% |
| Q4 2013 | $51,838,000 | +6.4% | 970,940 | 0.0% | 0.03% | +7.1% |
| Q3 2013 | $48,712,000 | +0.4% | 970,940 | 0.0% | 0.03% | -6.7% |
| Q2 2013 | $48,518,000 | +6.5% | 970,940 | 0.0% | 0.03% | 0.0% |
| Q1 2013 | $45,547,000 | +11.4% | 970,940 | +9.8% | 0.03% | +7.1% |
| Q3 2012 | $40,896,000 | +0.5% | 884,435 | 0.0% | 0.03% | -15.2% |
| Q2 2012 | $40,684,000 | – | 884,435 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |